Tumor necrosis factor inhibitors – state of knowledge

Tumor necrosis factor (TNF) is considered a major proinflammatory cytokine, affecting various aspects of the immune reaction. All five TNF inhibitors currently available on the market (i.e., etanercept, infliximab, adalimumab, certolizumab and golimumab) are top sellers, although indicated only in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lis, Krzysztof, Kuzawińska, Olga, Bałkowiec-Iskra, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296073/
https://www.ncbi.nlm.nih.gov/pubmed/25624856
http://dx.doi.org/10.5114/aoms.2014.47827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296073/
https://www.ncbi.nlm.nih.gov/pubmed/25624856
http://dx.doi.org/10.5114/aoms.2014.47827

Ejemplares similares